Testing for Antibodies to Human Immunodeficiency Virus Type 2 in the United States

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Superseded

This Document Has Been Replaced By: Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings

i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: Click to view more supporting documents

Testing for Antibodies to Human Immunodeficiency Virus Type 2 in the United States

July 17, 1992
Source: MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1992; 41(RR-12):1-9.

[HTM]

Select to view the document on External site.

This document file type cannot be previewed

English

Details You May Also Like

Details:

Description:

The Food and Drug Administration (FDA) has recommended that all donated blood be screened for antibodies to human immunodeficiency virus type 2 (HIV-2) beginning no later than June 1, 1992. This article provides CDC recommendations for the diagnosis of HIV-1 and HIV-2 infections in persons being tested in settings other than blood centers and CDC/FDA guidelines for serologic testing with combination HIV-1/HIV-2 screening enzyme immunoassays (EIAs).
Subjects:

[+]

Adult AIDS Serodiagnosis Blotting, Western Child Counseling Female HIV-1 HIV-2 HIV Antibodies HIV Infections Humans Immunoenzyme Techniques Male
Source:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1992; 41(RR-12):1-9.
Name as Subject:

Centers for Disease Control and Prevention (U.S.) ; Centers for Disease Control and Prevention (U.S.)

Centers for Disease Control and Prevention (U.S.) ; Centers for Disease Control and Prevention (U.S.) Less -
Place as Subject:

Africa, Western ; Europe ; United States

Africa, Western ; Europe ; United States Less -
Volume:

41
Collection(s):

Morbidity and Mortality Weekly Report (MMWR) Guidelines and Recommendations
Main Document Checksum:

[+]

urn:sha256:e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
File Type:

No Additional Files

More +

Superseded

Up-to-date Information

Testing for Antibodies to Human Immunodeficiency Virus Type 2 in the United States

Details:

Supporting Files

You May Also Like